Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$121,331,950
+$25,813,836 QoQ
Shares Held
101,158
-2.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
1.82%
of 13F equity value
Holder Rank
#345
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen/Frost Bankers, Inc. holds $397,272,361 across 15 Drug Manufacturers - General names. LLY ranks #1 (30.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
101,158 | $121,331,950 | |
| 2 | ABBV |
AbbVie Inc.
|
341,851 | $86,023,385 | |
| 3 | JNJ |
Johnson & Johnson
|
308,337 | $78,308,347 | |
| 4 | MRK |
Merck & Co., Inc.
|
309,626 | $39,786,941 | |
| 5 | AMGN |
Amgen Inc
|
69,521 | $25,174,944 | |
| 6 | NVO |
Novo Nordisk A S
|
341,905 | $16,390,925 | |
| 7 | AZN |
Astrazeneca PLC
|
84,701 | $16,061,003 | |
| 8 | PFE |
Pfizer Inc
|
209,637 | $5,048,058 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,331,950 | 101,158 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $95,518,114 | 103,850 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $111,414,235 | 103,672 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $79,432,878 | 104,106 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $80,945,615 | 103,839 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $84,873,815 | 102,764 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $78,769,476 | 102,033 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $90,816,823 | 102,509 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $93,119,238 | 102,851 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $81,092,216 | 104,237 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $63,212,427 | 108,441 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $62,349,513 | 116,079 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $55,377,158 | 118,080 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $41,484,449 | 120,798 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $44,287,492 | 121,057 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $36,490,694 | 112,852 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $35,414,994 | 109,228 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $30,511,864 | 106,547 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $28,710,859 | 103,942 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $24,715,880 | 106,972 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $23,503,076 | 102,401 | Shares | Other | 2021-08-05 | |
| 2021-03-31 | $19,811,700 | 106,047 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $17,877,791 | 105,886 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $14,744,124 | 99,609 | Shares | Other | 2020-11-05 | |
| 2020-06-30 | $3,861,021 | 23,517 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $3,316,794 | 23,910 | Shares | Other | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||